Oscar Health, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
The Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership in Oscar Health Inc. following an internal realignment.
NYSE
Dragoneer Investment Group, along with Marc Stad, filed an amended Schedule 13G disclosing beneficial ownership of 0.3% of Oscar Health, Inc.'s Class A Common Stock.
NYSE
SCHEDULE 13G/A: T. Rowe Price Trims Oscar Health Stake to 3.7%
T. Rowe Price Investment Management, Inc. has reported an amended beneficial ownership of 3.7% in Oscar Health Inc. Class A common stock.
NYSE
Deerfield Mgmt, L.P. and affiliated entities report 0% beneficial ownership in Oscar Health, Inc. Class A Common Stock.
NYSE
JPMorgan Chase & Co. has updated its passive ownership stake in Oscar Health, Inc., reporting a 4.5% beneficial ownership of Class A Common Stock.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.4% Passive Stake in Oscar Health
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.4% passive beneficial ownership stake in Oscar Health, Inc. as of June 30, 2025.
NYSE
JPMorgan Chase & Co. has reported a 6.4% beneficial ownership stake in Oscar Health, Inc.'s Class A Common Stock as of March 31, 2025, filed under SEC Rule 13d-1(b).